当前位置:首页 > 文献互助 > 互助详情

A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer.复制

用户IXngRDOWO6vw 10天前 46 10 已关闭

DOI:复制

文献链接: https://pubmed.ncbi.nlm.nih.gov/11529249复制

其他信息:

PMID: 11529249
作者: C Cunningham; J Nemunaitis; C Cunningham; C Cunningham; J Nemunaitis
摘要: An attenuated strain of Salmonella typhimurium, designated VNP20009, was generated by deletion of the msbB and purl genes. When VNP20009 was administered intravenously (IV) to mice bearing spontaneous, syngeneic, or human xenograft tumors, the bacteria accumulated preferentially within the extracellular components of tumors, forming tumor-to-normal tissue ratios exceeding 300-1000 to 1. NVP20009 was administered safely at doses up to 2.5 x 10(9) cfu/kg in monkey toxicology studies. Based on the ...

互助时间线

2025-04-13 13:37:47 [关闭求助]

系统关闭了求助

2025-04-08 13:37:47 [发起求助]